You are here

  • Home
  • Archive
  • Volume 70, Issue 11
  • The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies

Article info

Article menu
Download PDFPDF
Inflammatory bowel disease
Original research
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies

Authors

  • Thomas X Lu Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA Indiana University Health Southern Indiana Physicians, Bloomington, IN, USA The Graham School of Continuing Liberal and Professional Studies, University of Chicago, Chicago, IL, USA PubMed articlesGoogle scholar articles
  • Matthew Dapas The Graham School of Continuing Liberal and Professional Studies, University of Chicago, Chicago, IL, USA Department of Human Genetics, University of Chicago, Chicago, IL, USA PubMed articlesGoogle scholar articles
  • Erika Lin The Graham School of Continuing Liberal and Professional Studies, University of Chicago, Chicago, IL, USA PubMed articlesGoogle scholar articles
  • Trevor Peters The Graham School of Continuing Liberal and Professional Studies, University of Chicago, Chicago, IL, USA PubMed articlesGoogle scholar articles
  • Atsushi Sakuraba Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Atsushi Sakuraba, Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, IL 60637, USA; asakurab{at}medicine.bsd.uchicago.edu
View Full Text

Citation

Lu TX, Dapas M, Lin E, et al
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studies
Gut 2021;70:2076-2084.

Publication history

  • Received May 5, 2020
  • Revised November 24, 2020
  • Accepted November 25, 2020
  • First published December 17, 2020.
Online issue publication 
October 07, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.